• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 大流行期间传播的 SARS-CoV-2 变体的综合特征:来自印度恰蒂斯加尔邦的基因组特征研究。

A comprehensive profile of SARS-CoV-2 variants spreading during the COVID-19 pandemic: a genomic characterization study from Chhattisgarh State, India.

机构信息

Department of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

出版信息

Arch Microbiol. 2024 Jan 18;206(2):68. doi: 10.1007/s00203-023-03807-2.

DOI:10.1007/s00203-023-03807-2
PMID:38238530
Abstract

SARS-CoV-2 has expressively changed its sequences during the COVID-19 pandemic situation by encompassing persistent evolutionary mutational changes resulting in the emergence of many clades and lineages. Evolution of these SARS-CoV-2 variants have significantly imparted fitness advantage to the virus, enhanced its transmissibility and severity of the disease. These new variants are a potential threat to the vaccine efficacy as well. It is therefore pertinent to monitor the evolution of these variants and their epidemiological and clinical impact, in a geographic setting. This study has thus looked into the geographic distribution and genetic diversity of SARS-CoV-2 variants and the evolutionary circulation of different clades in Chhattisgarh (CG) state from March 2020 to July 2023. A total of 3018 sequences were retrieved from the GISAID database, in which 558 were submitted by us. The demographic data revealed male preponderance of 56.45% versus 43.54% females, with the overall mean age of 36.5 years. SARS-CoV-2 sequences represented many variants viz., Delta (55%), Omicron (22%) and others (15%) with a small proportion of recombinant (5%), Kappa (2%), and Alpha (1%). The viral clades G was found predominant for a year from initial days of pandemic in March, 2020 to January, 2021 which then subsequently evoluted to subclade GK (Delta B.1.617.2) and remained in circulation in CG till November, 2021. From December 2021, the GRA (Omicron B.1.1.529) variant had replaced GK to become the dominant strain and continues to predominate in present time. GRA clade is however continuously encompassing new recombinant strains, having various non-synonymous mutations especially in spike protein. The non-synonymous mutation P314L in ORF1b, S84L in ORF8 and D614G in spike protein were found as the pan mutation carried over from clade G to GRA. The continuous evolution in SARS-CoV2 warrants periodical geographic genomic surveillance monitoring to timely detect any new variants having the potential of causing future outbreak.

摘要

SARS-CoV-2 在 COVID-19 大流行期间明显改变了其序列,包括持续的进化突变,导致出现了许多分支和谱系。这些 SARS-CoV-2 变体的进化显著赋予了病毒适应性优势,增强了其传染性和疾病严重程度。这些新变体也对疫苗功效构成潜在威胁。因此,在地理环境中监测这些变体及其流行病学和临床影响至关重要。本研究因此调查了 2020 年 3 月至 2023 年 7 月恰蒂斯加尔邦(CG)中 SARS-CoV-2 变体的地理分布和遗传多样性,以及不同分支的进化循环。从 GISAID 数据库中总共检索到 3018 个序列,其中 558 个是我们提交的。人口统计学数据显示,男性占 56.45%,女性占 43.54%,平均年龄为 36.5 岁。SARS-CoV-2 序列代表了许多变体,如 Delta(55%)、Omicron(22%)和其他变体(15%),重组变体(5%)、Kappa(2%)和 Alpha(1%)比例较小。在 2020 年 3 月大流行初始阶段至 2021 年 1 月的一年中,发现分支 G 占主导地位,随后进化为亚分支 GK(Delta B.1.617.2),并在 CG 持续传播到 2021 年 11 月。从 2021 年 12 月起,GRA(Omicron B.1.1.529)变体取代了 GK 成为优势株,目前仍占主导地位。然而,GRA 分支不断包含新的重组株,在刺突蛋白中具有各种非同义突变。ORF1b 中的非同义突变 P314L、ORF8 中的 S84L 和刺突蛋白中的 D614G 被发现是从分支 G 到 GRA 的泛突变。SARS-CoV2 的持续进化需要定期进行地理基因组监测,以及时发现任何具有潜在引发未来爆发能力的新变体。

相似文献

1
A comprehensive profile of SARS-CoV-2 variants spreading during the COVID-19 pandemic: a genomic characterization study from Chhattisgarh State, India.COVID-19 大流行期间传播的 SARS-CoV-2 变体的综合特征:来自印度恰蒂斯加尔邦的基因组特征研究。
Arch Microbiol. 2024 Jan 18;206(2):68. doi: 10.1007/s00203-023-03807-2.
2
Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India.基因组特征分析揭示了 SARS-CoV-2 德尔塔变异株 B.1.617.2 在印度恰蒂斯加尔邦 COVID-19 大流行第二波中的致病作用。
Microb Pathog. 2022 Mar;164:105404. doi: 10.1016/j.micpath.2022.105404. Epub 2022 Jan 19.
3
SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.哥斯达黎加的 SARS-CoV-2 基因组监测:存在分化种群的证据,并增加了检测到刺突 T1117I 突变。
Infect Genet Evol. 2021 Aug;92:104872. doi: 10.1016/j.meegid.2021.104872. Epub 2021 Apr 24.
4
Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.SARS-CoV-2 的分子进化:2019 年 12 月至 2022 年 8 月。
J Med Virol. 2023 Jan;95(1):e28366. doi: 10.1002/jmv.28366.
5
Mutational cascade of SARS-CoV-2 leading to evolution and emergence of omicron variant.SARS-CoV-2 突变级联导致奥密克戎变体的进化和出现。
Virus Res. 2022 Jul 2;315:198765. doi: 10.1016/j.virusres.2022.198765. Epub 2022 Mar 31.
6
Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India.印度西孟加拉邦出现新型 SARS-CoV-2 Pango 谱系 B.1.1.526。
J Infect Public Health. 2022 Jan;15(1):42-50. doi: 10.1016/j.jiph.2021.11.020. Epub 2021 Dec 4.
7
Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?阿尔及利亚和北非国家新冠病毒的基因组多样性:我们目前所知及预期如何?
Microorganisms. 2022 Feb 18;10(2):467. doi: 10.3390/microorganisms10020467.
8
Spatiotemporal genome diversity of SARS-CoV-2 in wastewater: a two-year global epidemiological study.污水中 SARS-CoV-2 的时空基因组多样性:一项为期两年的全球流行病学研究。
Environ Monit Assess. 2023 Dec 16;196(1):44. doi: 10.1007/s10661-023-12228-z.
9
Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China.SARS-CoV-2 变异株的进化与系统发育动态:中国太原市与武汉市的遗传比较研究。
Viruses. 2024 Jun 3;16(6):907. doi: 10.3390/v16060907.
10
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.对 SARS-CoV-2 谱系的基因组监测表明,在巴西南部早期传播了令人关注的 P.1(Gamma)变体。
Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16.

引用本文的文献

1
Alpha to JN.1 variants: SARS-CoV-2 genomic analysis unfolding its various lineages/sublineages evolved in Chhattisgarh, India from 2020 to 2024.从阿尔法到JN.1变体:2020年至2024年在印度恰蒂斯加尔邦进化出的SARS-CoV-2基因组分析揭示了其各种谱系/亚谱系。
World J Virol. 2025 Jun 25;14(2):100001. doi: 10.5501/wjv.v14.i2.100001.

本文引用的文献

1
Angiotensin-II drives changes in microglia-vascular interactions in rats with heart failure.血管紧张素 II 驱动心力衰竭大鼠小胶质细胞与血管相互作用的变化。
bioRxiv. 2023 Dec 23:2023.12.22.573045. doi: 10.1101/2023.12.22.573045.
2
Identification of potential inhibitors against Mur D enzyme to combat rising drug resistance: an approach.鉴定抗Mur D酶的潜在抑制剂以应对不断上升的耐药性:一种方法
J Biomol Struct Dyn. 2025 Apr;43(7):3286-3296. doi: 10.1080/07391102.2023.2297007. Epub 2023 Dec 27.
3
An Analysis of COVID-19 Mortality in Chhattisgarh: A Two-Year Study on Demographics, Trends, and Impacts.
恰蒂斯加尔邦新冠肺炎死亡率分析:一项关于人口统计学、趋势及影响的为期两年的研究
Cureus. 2023 Aug 8;15(8):e43155. doi: 10.7759/cureus.43155. eCollection 2023 Aug.
4
The evolution of SARS-CoV-2.严重急性呼吸综合征冠状病毒2的进化
Nat Rev Microbiol. 2023 Jun;21(6):361-379. doi: 10.1038/s41579-023-00878-2. Epub 2023 Apr 5.
5
Genome surveillance of SARS-CoV-2 variants and their role in pathogenesis focusing on second wave of COVID-19 in India.SARS-CoV-2 变体的基因组监测及其在发病机制中的作用,重点关注印度 COVID-19 的第二波疫情。
Sci Rep. 2023 Mar 22;13(1):4692. doi: 10.1038/s41598-023-30815-5.
6
SARSMutOnto: An Ontology for SARS-CoV-2 Lineages and Mutations.SARSMutOnto:一个用于 SARS-CoV-2 谱系和突变的本体。
Viruses. 2023 Feb 11;15(2):505. doi: 10.3390/v15020505.
7
Evolution of the SARS-CoV-2 pandemic in India.印度新冠疫情的演变
Med J Armed Forces India. 2022 Jul;78(3):264-270. doi: 10.1016/j.mjafi.2022.05.006. Epub 2022 May 16.
8
Epidemiological Characteristics of the COVID-19 Pandemic During the First and Second Waves in Chhattisgarh, Central India: A Comparative Analysis.印度中部恰蒂斯加尔邦第一波和第二波新冠疫情期间的流行病学特征:一项对比分析
Cureus. 2022 Apr 13;14(4):e24131. doi: 10.7759/cureus.24131. eCollection 2022 Apr.
9
Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.2021年印度马哈拉施特拉邦接种疫苗后感染Delta变异株的新冠病毒病例的临床、免疫学和基因组分析
J Infect. 2022 Jul;85(1):e26-e29. doi: 10.1016/j.jinf.2022.04.014. Epub 2022 Apr 8.
10
GISAID's Role in Pandemic Response.全球流感共享数据库(GISAID)在大流行应对中的作用。
China CDC Wkly. 2021 Dec 3;3(49):1049-1051. doi: 10.46234/ccdcw2021.255.